Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
Interim timepoints not in PM
-
In our PM, the data for an endpoint are reported only for baseline and the final timepoint (example, Week 52). There is no mention of interim timepoints in the PM. However, the trial publication contains a chart showing the data for the interim time points (example, every 2 weeks) - would it be acceptable to include these charts, with the interim time points, in a branded, HCP-directed piece?
-
In our PM, the data for an endpoint are reported only for baseline and the final timepoint (example, Week 52). There is no mention of interim timepoints in the PM. However, the trial publication contains a chart showing the data for the interim time points (example, every 2 weeks) - would it be acceptable to include these charts, with the interim time points, in a branded, HCP-directed piece?
Hello @kbernard
Providing the published study meets PAAB requirements as a standalone trial, as a general rule of thumb, if the timepoints are predefined, tested for statistical significance, and are directionally consistent with the primary endpoint, it would be acceptable to present them in the piece in a non-selective and complete manner.
